Medical Services (CE) (USOTC:MSITF)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Medical Services (CE) Charts. Click Here for more Medical Services (CE) Charts.](/p.php?pid=staticchart&s=NO%5EMSITF&p=8&t=15)
EDMONTON, Alberta, June 8 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that its marketing program continues to be successful. The Company is receiving significant interest for the VScan products from Australia. Based on market studies and information received from companies interested in becoming distributors it becomes apparent that there is a large market for the VScan products. The Company expects to sign agreements with up to 4 companies to act as distributors in Australia. Based on commitments tentatively agreed to with the distributors, the Company believes that it will sell in excess of 1.2 million kits in the first year of operation in Australia. As it becomes apparent just how accurate the VScan products are, it is felt that the Company will sell up to 3.5 million VScan kits per year generating gross revenues in excess of 7.0 million.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, for Medical Services
International Inc.
Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/